Skip to main content

Articles

Prostate Cancer
Cabozantinib plus Atezolizumab Combination Shows Meaningful Activity in Metastatic Prostate Cancer
Phoebe Starr
Read More
FDA Approvals
FDA News: August 2020
Read More
Ovarian Cancer
Olaparib Extends Survival by >1 Year in Patients with Ovarian Cancer and BRCA Mutation, Ushering in Personalized Medicine in This Malignancy
Wayne Kuznar
Read More
Practice Management
ASCO 2020 Presidential Address: Accelerating Progress, Prioritizing Diversity
Wayne Kuznar
Read More
Prostate Cancer
Oral Relugolix Equals Standard ADT, Slashes Cardiac Events in Patients with Advanced Prostate Cancer
Phoebe Starr
Read More
Lung Cancer, Oncology
Adjuvant Osimertinib a Practice-­Changing Treatment in Early-Stage NSCLC with EGFR Mutation
Wayne Kuznar
Read More
Practice Management
Clinical Decision Support Helps Compliance with Evidence-Based Pathways
Chase Doyle
Read More
Practice Management
Cemiplimab Cost-Effective for Advanced Cutaneous Squamous-Cell Carcinoma
Chase Doyle
Read More
Practice Management
Germline Alterations Analysis Has Actionable Value in Selecting Targetable Treatments for Patients with Advanced Cancer
Chase Doyle
Read More
Practice Management
The Value of Some Cancer Drugs Changes Substantially After Their Approval
Chase Doyle
Read More
Page 32 of 244
Results 311 - 320 of 2434